|
CASP8AP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.138000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.501800E-01 |
| Normal-vs-Stage2 |
4.715400E-01 |
| Normal-vs-Stage3 |
1.011670E-02 |
| Normal-vs-Stage4 |
1.272150E-02 |
| Stage1-vs-Stage2 |
9.839800E-01 |
| Stage1-vs-Stage3 |
6.214400E-02 |
| Stage1-vs-Stage4 |
7.049800E-02 |
| Stage2-vs-Stage3 |
3.768000E-01 |
| Stage2-vs-Stage4 |
3.495400E-01 |
| Stage3-vs-Stage4 |
8.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023570E-01 |
| Normal-vs-AfricanAmerican |
8.502600E-03 |
| Normal-vs-Asian |
3.407200E-01 |
| Caucasian-vs-AfricanAmerican |
1.043970E-01 |
| Caucasian-vs-Asian |
1.364380E-01 |
| AfricanAmerican-vs-Asian |
3.659600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.125700E-02 |
| Normal-vs-Female |
2.523400E-01 |
| Male-vs-Female |
2.140600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.521400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.076800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.651650E-02 |
| Normal-vs-Age(81-100Yrs) |
1.909890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.089000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.415800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.196400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.176960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.477400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.186400E-01 |
| Normal-vs-Grade 2 |
7.256800E-01 |
| Normal-vs-Grade 3 |
7.177300E-04 |
| Normal-vs-Grade 4 |
5.596900E-03 |
| Grade 1-vs-Grade 2 |
2.406400E-01 |
| Grade 1-vs-Grade 3 |
1.237720E-03 |
| Grade 1-vs-Grade 4 |
5.838100E-03 |
| Grade 2-vs-Grade 3 |
3.576500E-04 |
| Grade 2-vs-Grade 4 |
4.276900E-03 |
| Grade 3-vs-Grade 4 |
6.922600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.039200E-01 |
| Normal-vs-ccB subtype |
1.089950E-02 |
| ccA subtype-vs-ccB subtype |
9.236800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.437200E-01 |
| Normal-vs-N1 |
1.784450E-01 |
| N0-vs-N1 |
5.016400E-01 |
|
|
